VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $1.8B
- YoY, 2025
- +19.7%
- 5-year CAGR
- +17.9%
- 10-year CAGR
- +16.6%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $1.8B | +19.7% |
| 2024 | $1.5B | +28.8% |
| 2023 | $1.1B | +20.3% |
| 2022 | $945M | +12.5% |
| 2021 | $840M | +9.0% |
| 2020 | $771M | +17.0% |
| 2019 | $659M | +18.1% |
| 2018 | $558M | +12.4% |
| 2017 | $496M | +14.6% |
| 2016 | $433M | +14.9% |
| 2015 | $377M | +23.3% |
| 2014 | $305M | −14.3% |
| 2013 | $356M | −17.7% |
| 2012 | $433M | +8.0% |
| 2011 | $401M | +113.4% |
| 2010 | $188M | +44.2% |
| 2009 | $130M | +28.5% |
| 2008 | $101M | — |